Searched for
VACCINE SAFETY
PIL challenges Centre’s HPV vaccination drive, seeks Supreme Court intervention over consent, safety and accountabilityA petition challenges the HPV vaccination program's implementation. It alleges violations of constitutional rights regarding informed conse...- Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violations, Cipla contests actionMaharashtra FDA cancelled Cipla's Pune C&F unit drug sale licenses due to serious storage and recall issues. Inspectors found unauthorized ...
- Varanasi flood preparedness: 198 boats, 21 flood posts, NDRF teams deployed; 61 relief camps, 24/7 control room set upVaranasi district administration has prepared 61 flood relief camps for affected families. These camps will provide accommodation, food, an...
- "We do not merely follow rules; we make rules": Rajnath Singh on India's growing global statureIndia now commands global attention and shapes international rules, according to Defence Minister Rajnath Singh. The nation is achieving si...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the possibility of hostilities resuming in the Gulf region, focus on risk management in the market. Why? Because fresh hostilities wi...
- Corporates urge employees to stay alert as H1N1 cases surgeH1N1 cases have increased significantly, and monsoon fevers are at seasonal highs. Companies are issuing safety guidelines and advising emp...
- Pennsylvania's MMR vaccination rate fell below 95%. Now two residents have died from measlesPennsylvania is facing its first measles fatalities in thirty-five years due to a rise in cases statewide, primarily affecting unvaccinated...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsHere’s one thing to watch for in the next few weeks: How does the street treat disappointments in the mid-cap segment? If the reaction is l...
- Moderna shares soar 159% in a day after cancer vaccine succeeds in late-stage trialModerna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, redu...
- H1N1 scare at Bengaluru Clarence High School: 500+ students & over 21 employees fall sick; offline classes suspendedH1N1 scare at Bengaluru Clarence High School: Clarence High School has decided to halt offline classes following a notable surge in illness...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Market breadth is important, especially at this point of time. It is a better indicator of both underlying sentiment and what is likely in ...
- Trump’s vaccine overhaul could bring more shots, higher costs for US familiesPresident Donald Trump's vaccine plan faces significant financial and logistical hurdles. Drugmakers must develop new manufacturing process...
- Why Meta is paying for controversial content - and what that means for the posts you seeABC News Verify found Facebook had monetised Australian accounts described as having white nationalist, neo-Nazi or anti-vaccine links. Acc...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is volatility? There is, of course, a mathematical definition. Then there is the human definition, which is how investors feel it. In ...
- Disease Outbreak in Congo: Ebola death toll crosses 2,000—What Americans need to knowAn Ebola outbreak in the Democratic Republic of Congo has surpassed two thousand confirmed deaths. This outbreak involves a different virus...
- Trump takes aim at childhood vaccine schedule, orders revampPresident Donald Trump announced an executive order for revised childhood vaccine recommendations. This order promotes spacing out vaccines...
- Trump administration pushes stricter oversight of food ingredientsThe Trump administration proposed a new rule for food companies. This rule requires reporting new ingredients to government regulators. It ...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Japan's Takeda bets on dengue vax to reshape India playbookTakeda Pharmaceutical's new dengue vaccine Qdenga received approval in India. The vaccine is expected to launch commercially in early 2027....
- ICAR develops indigenous African Swine Fever vaccine, strengthening India’s biosecurityDr. M.L. Jat, Secretary, DARE and Director General, ICAR said that this breakthrough marks the dawn of a new era in veterinary science.
Load More
